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complaints
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Abstract
Background: Current studies comparing musculoskeletal pain levels between the genders focus on a single point
in time rather than measuring change over time. The purpose of this study is to compare pain levels between
males and females before and after treatment.
Methods: Eleven different patient cohorts (3,900 patients) included in two prospective outcome databases
collected pain data at baseline and 1 month after treatment. Treatments were either imaging-guided therapeutic
injections or chiropractic therapy. The Mann–Whitney U test was used to calculate differences in numerical rating
scale (NRS) median scores between the genders for both time points in all 11 cohorts.
Results: Females reported significantly higher baseline pain scores at 4 of the 11 sites evaluated (glenohumeral
(p = 0.015), subacromial (p = 0.002), knee (p = 0.023) injections sites and chiropractic low back pain (LBP) patients
(p = 0.041)). However, at 1 month after treatment there were no significant gender differences in pain scores at any
of the extremity sites. Only the chiropractic LBP patients continued to show higher pain levels in females at
1 month.
Conclusions: In these 11 musculoskeletal sites evaluated before and after treatment, only 3 extremity sites and the
chiropractic LBP patients showed significantly higher baseline pain levels in females. At 1 month after treatment
only the LBP patients had significant gender differences in pain levels. Gender evaluation of change in pain over
time is likely to be more clinically important than an isolated pain measurement for certain anatomical sites.
Keywords: Gender differences, Pain intensity, Sex differences, Outcomes, Pain
Background
While everyone with an intact nervous system experi-
ences physical pain, research has shown that the
reported intensity and prevalence of pain arising from
the musculoskeletal system appears to differ between
males and females [1,2]. Specifically, there is a higher
prevalence of pain in females suffering from headaches,
neck and back pain, as well as knee pain, and this
increased prevalence starts during adolescence [1]. A re-
cent report from the United States also suggests that
pain is under diagnosed and under treated in females
[3]. Several studies focusing on musculoskeletal (MSK)
pain and gender report that females are more likely to
experience chronic pain, more likely to receive treatment
for chronic pain compared to males, and report signifi-
cantly higher pain intensity scores [4-6]. What remains
unknown is the reason for these higher prevalence rates
of pain in females. Do they reflect differences between
males and females in willingness to seek medical care as
has been suggested in previous research [1]?
Two recent systematic reviews of the literature look-
ing at these gender differences in an experimental en-
vironment concluded that males have significantly
more efficient diffuse noxious inhibitory controls
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(DNIC) compared to females and females are less tol-
erant to thermal stimuli and pressure pain, but not to
ischemic pain. But the weight of the evidence does not
show a clear and consistent pattern of gender differ-
ences in pain sensitivity [7,8]. However, all studies in
these systematic reviews were conducted in the labora-
tory setting and it is unknown how closely these
results reflect what is seen in daily clinical practice.
Although it has been suggested that pain management
should take these baseline gender pain differences into
account [1], it has yet to be shown that higher base-
line pain levels indicate a worse response to treatment.
Current studies compare reported pain levels between
males and females at a single point in time rather than
assessing changes over time [1,2,4-8].
This specialized orthopaedic/rheumatology university
hospital began collecting prospective outcomes data dur-
ing 2009–2010 and this is ongoing in both the radiology
and chiropractic departments in order to create large
databases for research and quality assurance purposes.
Patients undergoing imaging-guided therapeutic muscu-
loskeletal injections and patients being treated by chiro-
practors for neck pain, low back pain, and imaging
confirmed symptomatic disc herniations are included
in these databases. Because the literature consistently
reports gender differences in pain levels and preva-
lence based on anatomical region [1-6], assumptions
have been made about how this should influence treat-
ment [1]. Therefore the purposes of this study were to
first assess gender differences in baseline pain levels
based on anatomical site in patients of this specialized
orthopaedic/rheumatology hospital and second whether
any baseline gender differences in pain levels contin-
ued 1 month after the start of treatment.
Methods
This is a prospective outcomes study with 1 month
follow-up on 11 different cohorts of patients using two
large databases, one from the radiology department and
the other from the chiropractic department. The study
was conducted in a specialized orthopaedic/rheumatology
university hospital. Ethics approval was obtained from
the Canton of Zürich ethics commission prior to the
start of the databases (EK-12/2009, EK-16/2009, EK-19/
2009, EK-22/2009) and all patients signed informed con-
sent immediately prior to their therapeutic intervention.
No patient was included in any of the databases more
than once.
Imaging-guided musculoskeletal injections patient
Selection
Consecutive patients over the age of 18 with pain
strongly suspected to arise from the particular joint,
nerve root or spinal canal targeted for injection and who
had not responded to conservative treatments were
included. Exclusion criteria included joint injections not
intended for pain therapy (i.e. arthrography, joint aspir-
ation for infection or biopsy). Patients with overlying
skin infections or who were pregnant were also
excluded. Patients on anticoagulants were excluded from
having spine injections but not from the peripheral joint
injections.
Only those imaging-guided injection sites with at least
100 patients in the current database were included for
analysis in order to limit this study to the most common
MSK injection sites. This included cervical indirect
nerve root blocks, lumbar epidural injections, lumbar
facet joint injections, and lumbar nerve root blocks for
the spine. Extremity injection sites included the gleno-
humeral, subacromial, knee and hip joints.
Chiropractic treatment patient selection
New patients over the age of 18 with back pain, neck
pain, or magnetic resonance imaging (MRI) confirmed
symptomatic lumbar disc herniation of any duration
who had not received chiropractic or manual therapy in
the prior 3 months were recruited from multiple chiro-
practic practices in Switzerland. Patients with specific
abnormalities of the lumbar spine that are contraindi-
cations to chiropractic manipulative treatment, including
tumors, infections, inflammatory spondylo-arthropathies,
acute fractures, Paget’s disease and severe osteoporosis
were excluded.
Only the treatment sites with a minimum of 100
patients in the database were included in this study.
Neck pain patients, low back pain patients, and patients
with the specific MRI confirmed diagnosis of symptom-
atic lumbar disc herniation met this criterion. Patients in
the cervical disc herniation database were not included
due to the current small sample size.
General imaging-guided injection protocol
Under imaging guidance, a needle was placed into the
relevant joint, adjacent nerve root or lumbar interlami-
nar space. A non-neurotoxic contrast agent was then
injected to confirm correct needle placement. Once cor-
rect needle placement was confirmed, an injection of a
local anesthetic (Naropin 0.2%) was delivered, followed
by an injection of corticosteroid (Figures 1 and 2). The
exact quantities of these injectates were determined by
the specific joint or area being treated.
Chiropractic treatments
Thirty two different Swiss chiropractors contributed
patients to the chiropractic outcomes database and no
individual data was collected concerning the specific
treatments offered to each patient. However, data col-
lected from the Swiss Job Analysis Study of
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chiropractors in 2009 [9] indicated that spinal manipula-
tive therapy (SMT) using an approach known as the
‘Diversified’ technique was the most common treatment
and applied to between 76 and 100% of patients. The
other common additional treatments used included ad-
vice on the activities of daily living, trigger point therapy,
therapeutic exercises and mobilization techniques.
Data collection
The eleven point NRS (numerical rating scale) where 0
is no pain and 10 is the worst pain imaginable was used
for all patients in the two databases. This value was
recorded for the level of current pain in the radiology
department immediately prior to the imaging-guided
therapeutic injection or in the respective chiropractic
clinics prior to the chiropractic treatment procedure.
One month after the first treatment, patients who had
received an imaging-guided therapeutic musculoskeletal
injection returned a paper-based postal questionnaire
which included information on their current pain level
using the NRS scale. Chiropractic patients had this exact
same data collected one month after the first treatment
via telephone calls from trained independent research
assistants. Data was manually entered into SPSS version
17.0 by one of the authors and one research assistant.
Statistical analysis
Means and standard deviations (SD) were calculated for
the two data collection time points by gender for each
injection and chiropractic treatment site. Because the
NRS data was skewed toward the upper end of the pain
scale, the non-parametric Mann–Whitney U test was
used to assess for significant differences between the
genders for baseline NRS, 1 month NRS, and the NRS
change score median values at 1 month for each region.
P < 0.05 was determined to be significant. However, the
mean values rather than the median values are reported
in the tables to make the data easier to relate to the NRS
scale and for comparison with other prior studies. Spear-
man’s correlation coefficient was used to evaluate the
relationship between age and baseline NRS scores for
each of the 11 cohorts.
Results
Data was available for 3,900 patients, 1,954 from the
imaging-guided therapeutic injections database and
1,946 from the chiropractic treatment database. Of these
patients 1,855 (48%) were males. Of the four spinal in-
jection sites, there was a higher prevalence of females
for both epidural (61%) and lumbar facet (55%) injec-
tions (Table 1). A slight predominance of male patients
received cervical (55%) or lumbar (52%) nerve root
injections. A higher prevalence of female patients was
found in 3 of the 4 extremity injection sites. Women
made up 52% of the gleno-humeral joint injections, 57%
of the knee injection patients and 58% of the hip injec-
tion patients (Table 2). Fifty six percent of the subacro-
mial injection patients were males.
In the chiropractic treatment database, a strong preva-
lence of female patients was found for neck pain (62%)
but a very slight male predominance (51%) was noted
for low back pain patients. The lumbar disc herniation
patients showed a very strong male prevalence of 79%.
Comparing the two genders for the imaging-guided
spinal injections showed no significant differences in
baseline NRS scores, 1 month NRS scores, or 1 month
NRS change scores for any of the injection sites
(Table 1). However, 3 of the 4 extremity injections
sites (gleno-humeral (p = 0.015), subacromial (p = 0.002),
knee (p=0.023)) showed significantly higher pre-treatment
(baseline) NRS scores for the female patients (Table 2).
However, by 1 month there were no significant
Figure 1 Imaging-guided subacromial injection showing
contrast in the subacromial space.
Figure 2 Imaging-guided right L2-3 facet injection showing the
needle and contrast within the joint.
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differences in the NRS scores between the genders for
any of these extremity injection sites. The one month
NRS change score for subacromial injections was
significantly (p = 0.045) greater for the female patients.
For the patients undergoing chiropractic treatment for
low back pain (n = 1065), there was a significant differ-
ence in the baseline pre-treatment NRS scores between
males and females (p = 0.041) with females reporting
higher scores. At 1 month the difference between the
genders was higher (p = 0.001) (Table 3). Chiropractic
patients with MRI confirmed lumbar disc herniations
(n = 139) and patients treated for neck pain (n = 742)
showed no significant differences in baseline NRS
scores, 1 month NRS scores, or 1 month NRS change
scores, between males and females.
Assessing for significant age differences between the
genders for each of the 11 musculoskeletal sites found
that females were significantly older for 3 of the
imaging-guided injection sites and males were signifi-
cantly older for chiropractic patients treated for low
back pain (Table 4). None of the other sites had signifi-
cant age differences between the genders. There were no
significant correlations between patient age and baseline
NRS scores for any of the cohorts however.
Discussion
To our knowledge, this is the first study to specifically
compare reported pain levels between males and females
at specific anatomical sites before and after various mus-
culoskeletal therapies using a large electronic database.
Of the 11 musculoskeletal sites evaluated, females reported
significantly higher baseline pain levels prior to gleno-
humeral, subacromial and knee injections as well as LBP
patients undergoing chiropractic treatment. However at
1 month after treatment there was no significant difference
in NRS scores between the genders for the 3 extremity
injection sites, indicating a better response for women.
Only the LBP patients receiving chiropractic treatment
continued to show the same gender difference in pain
levels at one month. Although this may appear to
Table 1 Gender comparisons for Pain with Spinal Injections
PROCEDURE DATA TIME POINT MALES Mean (SD) FEMALES Mean (SD) P-VALUE
Cervical Nerve Root Injections (n = 132) Baseline NRS 6.27 (2.33) n = 73 6.94 (2.23) n = 59 0.998
1 Month NRS 3.01 (2.96) 3.53 (2.86) 0.361
1 Month NRS Change score 3.19 (2.93) 3.08 (2.74) 0.890
Epidural injections (n = 165) Baseline NRS 6.12 (2.33) n = 65 6.55 (2.49) n = 101 0.492
1 Month NRS 4.15 (3.01) 3.73 (2.60) 0.582
1 Month NRS Change score 1.89 (2.67) 2.65 (3.20) 0.159
Lumbar Facet injections (n = 424) Baseline NRS 6.53 (2.12) n = 191 6.79 (2.23) n = 233 0.148
1 Month NRS 4.21 (2.55) 4.61 (2.65) 0.172
1 Month NRS Change score 2.31 (2.58) 2.16 (2.72) 0.590
Lumbar Nerve Root injections (n = 400) Baseline NRS 6.53 (2.27) n = 208 6.54 (2.23) n = 192 0.295
1 Month NRS 3.75 (2.81) 3.79 (2.88) 0.611
1 Month NRS Change score 2.74 (3.19) 2.70 (3.01) 0.994
n = number of patients. NRS = Numerical Rating Scale for pain. SD = standard deviation.
Table 2 Gender comparisons for Pain with Extremity Injections
PROCEDURE DATA TIME POINT MALES Mean (SD) FEMALES Mean (SD) P-VALUE
Gleno-Humeral Injections (n = 224) Baseline NRS 5.79 (2.11) n = 107 6.51 (2.22) n = 117 0.015*
1 Month NRS 2.72 (2.29) 3.00 (2.62) 0.791
1 Month NRS Change score 3.03 (2.46) 3.51 (2.44) 0.112
Subacromial Injections (n = 165) Baseline NRS 5.88 (2.08) n = 93 6.74 (1.75) n = 72 0.002*
1 Month NRS 2.49 (2.19) 2.59 (2.32) 0.468
1 Month NRS Change score 3.38 (2.88) 4.27 (3.01) 0.045*
Knee Injections (n = 309) Baseline NRS 6.10 (2.58) n = 134 6.76 (2.08) n = 175 0.023*
1 Month NRS 4.56 (2.88) 4.68 (2.95) 0.418
1 Month NRS Change score 1.51 (2.80) 2.07 (2.96) 0.357
Hip Injections (n = 135) Baseline NRS 5.78 (2.49) n = 57 6.47 (1.92) n = 78 0.387
1 Month NRS 4.11 (2.75) 4.51 (2.79) 0.886
1 Month NRS Change score 1.67 (2.52) 2.01 (2.61) 0.422
n = number of patients. NRS = Numerical Rating Scale for pain. * = p < 0.05. SD = standard deviation.
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support previous studies claiming that women report
higher pain intensity compared to men [2,4,5], it also
shows that only evaluating pain levels at one point in
time may not be sufficient to obtain the true clinical pic-
ture, at least for some anatomical sites, and that the
change in pain over time may be more important to the
patient. Indeed, the female patients having the gleno-
humeral, subacromial and knee injections had larger
1 month NRS change scores, which was statistically sig-
nificant for the subacromial injection patients. These
findings also do not support the suggestion that because
females have higher baseline pain scores that they should
be treated differently from males [1,3,6] nor does it agree
with the findings from a recent review article stating that
females tend to report higher levels of acute post-
procedural pain [6], at least not for these imaging-guided
injection procedures at this hospital. There were no areas
in this study where male patients reported significantly
higher baseline pain levels. The mechanism behind the
fact that although females present with higher baseline
pain levels for 4 of the 11 treatment sites, after treat-
ment there is no gender difference in pain levels for the
extremity injection patients is currently a mystery. If
males have more efficient diffuse noxious inhibitory con-
trols compared to females as reported in the literature
[7,8], it would be expected that this gender difference in
pain levels would persist.
Although there were statistically significant differences
in baseline pain levels between the genders for 3 extrem-
ity injection sites and for chiropractic LBP patients, an
important question to ask is whether or not these nu-
merical differences are actually clinically relevant? Most
previous studies reporting on gender differences in pain
levels have not addressed this issue [1-6]. Indeed studies
evaluating clinically meaningful pain differences have fo-
cused on the quantity of pain reduction levels with treat-
ment rather than meaningful differences in pain levels
between subgroups at the same time point [10-12]. It
has been suggested that using the 11 point NRS, as was
done in this study, a reduction of at least 1.3 points (or
20%) for patients experiencing moderate pain corre-
sponds to ‘minimal’ improvement [11]. However, it is
currently unknown if this same value can be considered
the minimal meaningful difference between the genders
at the same time point. In this current study the actual
numerical difference between males and females for the
baseline NRS scores that were statistically significantly
different ranged from a low of .23 points for the chiro-
practic LBP patients to a maximum of .86 points for
the subacromial injection patients. At least for the LBP
patients it can be strongly suggested that this is not a
clinically relevant pain difference between the genders.
The large sex differences pain study published recently
by Ruau et al. [2] reported gender differences in pain
Table 3 Gender comparisons for Pain for Chiropractic patients
PROCEDURE DATA TIME POINT MALES Mean (SD) FEMALES Mean (SD) P-VALUE
Low Back Pain Chiropractic Pts (n = 1065) Baseline NRS 5.68 (2.12) n = 538 5.91 (2.27) n = 527 0.041*
1 Month NRS 2.29 (2.03) 3.03 (2.33) 0.0001*
1 Month NRS Change score 3.38 (2.62) 2.82 (2.83) 0.001*
Lumbar Disc Herniation Chiropractic Pts (n = 139) Baseline NRS LBP 5.84 (2.78) n = 110 6.06 (3.27) n = 29 0.344
Baseline NRS Leg 5.35 (3.18) 5.50 (3.22) 0.852
1 Month NRS LBP 2.27 (1.95) 2.71 (2.23) 0.203
1 Month NRS Leg 2.31 (2.26) 2.17 (2.29) 0.756
1 Month NRS LBP Change score 3.39 (2.88) 3.42 (3.49) 0.728
1 Month NRS Leg Change score 2.97 (2.71) 3.62 (3.08) 0.672
Neck Pain Chiropractic Pts (n = 742) Baseline NRS 5.56 (2.10) n = 279 5.87 (2.36) n = 463 0.073
1 Month NRS 2.54 (2.15) 2.83 (2.28) 0.303
1 Month NRS Change score 2.98 (2.52) 2.99 (3.01) 0.666
n = number of patients. NRS = Numerical Rating Scale for pain. LBP = Low back pain. Pts = Patients. * = p<0.05. SD = standard deviation.
Table 4 Treatment sites with statistically significant age differences between the genders
Treatment Site Males Mean age in years (SD) Females Mean age in years (SD) P-value
Epidural Injections 55.79 (16.94) 61.44 (17.61) 0.04
Lumbar Facet Injections 61.07 (13.75) 64.44 (12.54) 0.009
Knee Injections 54.64 (12.23) 58.38 (13.88) 0.014
Chiropractic treatment for LBP 44.89 (14.58) 41.76 (14.36) 0.0001
SD = standard deviation. LBP = low back pain.
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levels at one point in time for many anatomical sites
and diagnoses and stated that research should look at
the mechanisms behind these differences and clinicians
should be paying more attention to these differences.
However, a careful analysis of their data also shows
small actual numerical differences between the genders
for all of the areas that they reported ranging from .23
points to 1.14 points on the NRS scale. That study
had a very large sample size and therefore small differ-
ences can become statistically significant but perhaps
not clinically relevant.
Of the 7 different spinal sites evaluated before and
after treatment, the only significant difference in out-
come was for chiropractic patients treated for low back
pain. Unlike previous European studies which reported
that females have a higher prevalence of low back pain
[4,13-17], in this current study there were slightly more
males (51%) seeking chiropractic treatment for low back
pain, and the male patients reported significantly less
pain and more clinically relevant improvement than
females at 1 month. However, no attempt was made to
stratify these 1,065 low back pain patients by specific
diagnosis in this study. For the low back pain patients
referred for the three different imaging-guided spinal
injections, it is likely that there was more homogeneity
in their diagnoses, particularly for the epidural and
lumbar nerve root injection patients. MRI and clinical
evidence of spinal stenosis in the patients receiving
epidural injections or nerve root compression in the
patients undergoing nerve root blocks was typical.
Interestingly, there was a higher prevalence of female
patients (61%) having epidural spinal injections, and
they were significantly older than their male counter-
parts. However, their reported pain and functional
levels at baseline and 1 month after injection were no
different from those reported by the male patients.
It is well established that males are more likely to have
lumbar disc herniations [18,19]. However, the extremely
high prevalence of 79% in the homogenous group of
chiropractic patients with MRI confirmed lumbar disc
herniations is most likely due to the fact that all data
collected for this part of the database came from only
one practice which includes three different male chiro-
practors. This particular practice is quite well known for
treating these types of patients and the chiropractors
themselves commented that their practice does attract a
disproportionate number of male patients compared to
other local practices [9].
The majority of neck pain patients in the chiropractic
database were female (62%) as expected based on previ-
ous research [1], but for this area of the spine their base-
line pain scores and outcomes were not significantly
different from the male patients. As with the low back
pain patients undergoing chiropractic treatment, this
study also did not attempt to categorize the over 700
neck pain patients by specific diagnosis. Future studies
should evaluate outcomes by gender as well as specific
diagnosis. The only neck pain patients undergoing
imaging-guided injections assessed in this study were
those having indirect nerve root blocks. These were
done if the pain was thought to arise from compression
of a cervical nerve root from disc herniation, degenera-
tive intervertebral foraminal stenosis, or a combination
of the two, as determined clinically and often assisted
with MRI scans. This is therefore a rather homogenous
group of patients and unlike the chiropractic neck pain
patients, showed a higher proportion of males (55%),
consistent with the gender prevalence of cervical disc
herniations reported in the literature [20]. However,
there were no gender differences for pain at baseline
or any of the outcomes measured at 1 month after
injection.
Limitations to the study
The main limitation to this study is the fact that only
patients presenting for specific treatments involving
the musculoskeletal system were included due to the
availability of information from large databases. Ex-
trapolation of these results to other anatomical sites or
treatments cannot be done without additional research.
Furthermore, for most of the 11 sites assessed, specific
diagnoses were not easily available or confirmed. Fur-
ther research into differences in reported pain levels
based on gender for patients with confirmed diagnoses
or specific abnormalities observed on diagnostic im-
aging would be valuable.
Additional demographic variables should also be con-
sidered when comparing the genders for pain differ-
ences. These could include factors such as duration of
pain, ethnicity, work status, body mass index, level of
physical activity and medication usage. This information
was not available for most of these current patients and
represents another limitation. Comparison of pain differ-
ences by age categories was also not done in this study
and could potentially be relevant as increasing age has
previously been shown to increase pain sensitivity [21].
However, of the 4 sites where a significant age difference
between the genders was found (Table 4), only the knee
injection site had a gender difference in baseline pain
level. Additionally, there was no significant correlation
between patient age and baseline pain scores for the 11
cohorts in this study. However, although there was no
linear relationship between patient age and baseline pain
levels, this does not rule out a non-linear relationship
which could be a confounder for the results.
Only those anatomical treatment sites that had at least
100 patients in the database were assessed for this study.
This occurred for two reasons. The first was to make
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sure that the sample sizes were large enough to detect
any gender differences. The second reason was prag-
matic as there are currently 67 different MSK injection
sites with data in the radiology database, some with only
a few patients. It was felt that including most of these
anatomical sites in this study at this time would not add
meaningful information.
Additionally, as these were all prospective outcomes
studies rather than randomized clinical trials, the im-
provement in pain levels and overall outcomes cannot
definitively be attributed to any of these treatments. An-
other limitation is that only change in pain at 1 month
after treatment was measured rather than longer-term
outcomes. However, chiropractic studies at least, have
shown that if patients are likely to improve, they do so
quite quickly after the start of treatment [22-24].
Conclusions
Although 4 of the 11 musculoskeletal areas evaluated
found that women had significantly higher baseline pain
scores, three of which were extremity injection sites, at
1 month post-injection there were no gender differences
in pain levels for these three sites. Only LBP patients re-
ceiving chiropractic treatment demonstrated statistically
significant gender differences in baseline and 1 month
pain levels. The actual numerical differences in the pain
scores that did show statistically significant differences
were not large, particularly for the chiropractic LBP co-
hort. It is therefore questioned whether or not these
baseline gender differences in pain levels are actually
clinically relevant. This shows that it may be important
to measure pain levels over time, at least for certain ana-
tomical sites, to obtain an accurate clinical picture. Al-
though chiropractic patients suffering from neck pain
were predominately women, there were no differences in
baseline pain scores or any outcome measure at 1 month
compared to men. It cannot be ruled out however, that
the gender differences observed were due to differences
in other covariates that were not measured due to their
lack of availability. Future studies comparing pain levels
between the genders should explore differences in
adjusted models.
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